Riskpilot← Back to searchSign inGet full accessRednalyn Rep Taparpan AB
ABDissolvedOrg 5563853455Other human health activities · NACE 8690Est. 19901 employees
Revenue 2023
SEK 1,4M
+1% vs 2022
EBITDA margin
16.3%
-23% vs 2022
Equity ratio
80.1%
Financial strength
Net profit 2023
SEK 247K
-20% vs 2022
| Revenue | SEK 1,4M | +1% |
| EBITDA | SEK 221K | -23% |
| Net profit | SEK 247K | -20% |
| Total assets | SEK 692K | -22% |
| Equity | SEK 554K | -9% |
| Employees | 1 | — |
Legal name
Rednalyn Rep Taparpan AB
Org number
5563853455
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
30 januari 1990
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av externa firmatecknaren
Company purpose
Bolaget skall bedriva konsultationer inom företagsorganisation, handel med aktier och värdepapper samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 1 369 | 1 360 | 1 338 | 1 343 | 1 356 |
| Staff expenses | — | — | — | −779 | −819 |
| EBITDA | 225 | 366 | 323 | 287 | 221 |
| Depreciation & amort. | −45 | −60 | −35 | −6 | — |
| EBIT | 180 | 306 | 288 | 282 | 221 |
| Net financials | — | — | — | −0 | 0 |
| Profit before tax | 185 | 280 | 288 | 391 | 311 |
| Tax | −41 | −60 | −62 | −82 | −64 |
| Net profit | 144 | 220 | 226 | 309 | 247 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 728 | 722 | 970 | 881 | 692 |
| Equity | 381 | 371 | 598 | 607 | 554 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 172 | 151 | 172 | 184 | 138 |
| Total debt | 172 | 151 | 172 | 184 | 138 |
EBITDA margin
16.3%
This company
15.8%
Market median
+3% vs market
20192023
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20192023
Return on equity
44.6%
This company
18.4%
Market median
+142% vs market
20192023
Net profit margin
18.2%
This company
8.1%
Market median
+125% vs market
20192023
Asset turnover
1.96×
This company
1.12×
Market median
+75% vs market
20192023
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GS External Signatory | External Signatory | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rednalyn Rep Taparpan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gun Sigrid Elisabeth Granlöf | External Signatory | 0 companies |
| Lars Wolger Svedin | Board of Directors | 0 companies |
| Lars Wolger Svedin | Board of Directors | 0 companies |
| Per Anton Wilhelm Uhlin | Deputy Board Member | 0 companies |